Issue 29 Demystifying & Advocating for PMS: The Role of Catalytic Investments in Menstrual Health by Pharmaceutical Industry of Pakistan
Message from Editor in Chief
Premenstrual Syndrome (PMS) is a condition that affects a substantial number of women during their reproductive years. Despite its prevalence, PMS remains shrouded in stigma, misinformation, and a lack of comprehensive understanding. The impact of PMS on women's lives can be profound, affecting their personal relationships, work performance, and overall quality of life. Yet, despite its significant impact, PMS is often dismissed or misunderstood, leaving many women to suffer in silence. Raising awareness about PMS is crucial for several reasons. Firstly, it helps to break down the stigma and silence surrounding menstruation and menstrual health. By normalizing conversations about PMS, we can foster a more supportive and understanding environment for women. Secondly, greater awareness leads to better diagnosis and treatment. Many women do not seek medical help for PMS because they believe their symptoms are a normal part of the menstrual cycle. However, severe PMS, also known as Premenstrual Dysphoric Disorder (PMDD), requires medical intervention. By educating women about the signs and symptoms of PMS and PMDD, we can encourage them to seek appropriate care. Lastly, advocacy efforts can drive policy changes that support women's health. This includes ensuring access to menstrual products, providing workplace accommodations for women experiencing severe PMS, and promoting research into the causes and treatments of PMS.
The pharmaceutical and nutraceutical industries in Pakistan have a critical role to play in advancing menstrual health and supporting women with PMS. Through innovation, research, and strategic investments, these industries can develop effective treatments and interventions that improve the quality of life for women. As we embark on this journey to demystify and advocate for menstrual health, I urge the pharmaceutical and nutraceutical industries in Pakistan to take a proactive role in advancing menstrual health.
This issue of She Matters is a special issue on the theme “Demystifying & Advocating for Premenstrual Syndrome: The Role of Catalytic Investments in Menstrual Health by the Pharma and Neutraceutical Industry of Pakistan”. This issue showcases Medics Laboratories: A Herbal and Phytopharmaceutical firm actively working to improve menstrual health in Pakistan. The issue features interviews of the team of FC Forte highlighting their advocacy for pre-menstrual syndrome. The issue also showcases the peaceful periods awareness campaign launched by Medics. I would like to acknowledge that launching this issue would not have been possible without the great and much appreciated contributions from the editorial and technical team. The robust intellectual support and well time contribution of content writers deserve special appreciatory applause. Our team expects similar sort of sincere dedication from the writers in near future. Enjoy reading the issue!